qlsyy.net (QLI) Net Asset Value

Corporate company logo of Qilian International Holding (QLI)

The price chart for Qilian International (QLI) reflects the price action of an asset whose business relies on the production of basic chemicals and antibiotics in China, ensuring stable sales without innovation costs, with the metric standing at 0.04. However, trade wars with the US pose a threat of export blocks, while local licenses are offset by potential costs for the environmental modernization of plants.

QLI Qilian International Holding Group Limited Book Capitalization (07/04/2022 - 08/17/2024)
Flagship merchandise of Qilian International Holding Group Limited

Book value capitalization reflects the value of net assets minus liabilities, serving as an indicator of the business's real asset foundation. By analyzing the book value capitalization trend, an investor assesses the dynamics of the material base of Qilian International (QLI), where growth in this metric directly correlates with the expansion of plant production capacities and an increase in available sowing areas for raw plant material procurement.

Competitors of Qilian International

HLN: Book Valuation of Business|Company Book Value Kenvue Inc. (KVUE)|veronapharma.com (VRNA) - Net Asset Value|MENS - Book Capitalization|Accounting Value of Company Ligand Pharmaceuticals Incorporated|Book Capitalization AMRX|Book Capitalization PRGO (Perrigo Corp)|Company Book Value Alvotech|liquidia.com - Accounting Value of Company|GLPG: Company Book Value|ANIP - Company Net Assets|MNKD: Book Capitalization|Book Capitalization Amphastar Corp|PCRX - Company Net Assets|Accounting Value of Company SPRY|Theravance Biopharma, Inc. - Company Book Value|Total Stockholders' Equity Aquestive Therapeutics Inc AQST|Company Net Assets scPharmaceuticals (SCPH)|Total Net Assets Tectonic Therapeutic Inc. TECX|Book Capitalization Tonix Pharmaceuticals (TNXP)|SXTC - Accounting Value of Company|Book Capitalization EPRX|BHST (BioHarvest Sciences, Inc.) - Total Stockholders' Equity|EXOZ - Company Book Value|Accounting Value of Company ORMP|ENTX: Company Book Value|Book Value of Business ipatherapeutics.com (HYFT)|Book Capitalization ABVC|Cumberland Pharmaceuticals Inc - Book Valuation of Business|QNTM - Company Book Value|FGEN - Company Book Value|Telomir Pharmaceuticals - Book Capitalization|Rani Therapeutics Holdings, Inc. (RANI) - Book Valuation of Business|SNYR (Synergy CHC Corp.) - Book Capitalization|Book Capitalization RLYB|Company Book Value Lexaria Bioscience LEXX|Accounting Capitalization Pulmatrix Corporation PULM|Company Net Assets Pheton Holdings|Accounting Value of Company Aptorum Group Ltd APM|Book Capitalization LYRA (Lyra Therapeutics)|IBO: Book Valuation of Business|Company Book Value tnfpharma.com|Accounting Capitalization cbdMD|PainReform Ltd. (PRFX) - Company Net Assets|Total Net Assets Auris Medical|Lipella Pharmaceuticals, Inc. - Book Capitalization|Total Stockholders' Equity OPTN (OptiNose Inc)|Company Book Value Pieris|Procaps Group Corp - Accounting Value of Company|Petros Pharmaceuticals (PTPI) - Company Book Value|SLRN - Accounting Capitalization|TFFP: Book Capitalization